Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€95.87

€95.87

-0.320%
-0.31
-0.320%
€137.75
 
21.07.25 / Tradegate WKN: 929138 / Symbol: A / Name: Agilent / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Agilent Technologies Inc. Stock

The price for the Agilent Technologies Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.310 (-0.320%).
Currently there is a rather positive sentiment for Agilent Technologies Inc. with 15 Buy predictions and 3 Sell predictions.
As a result the target price of 137 € shows a positive potential of 42.9% compared to the current price of 95.87 € for Agilent Technologies Inc..
Criterium "Business model" is seen as the biggest plus for Agilent Technologies Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Agilent Technologies is a leading global manufacturer of measuring instruments, software, services, and solutions for chemical analysis, life sciences, diagnostics, and electronic testing. The company provides a broad range of products from laboratory equipment to genetic testing tools and clinical diagnostics. Agilent's instruments are widely used in research laboratories, pharmaceutical companies, and government agencies, making it a significant player in the life sciences industry. The company operates in more than 100 countries and has a history of innovation, having developed some of the world's first portable gas chromatographs and UV-Vis spectrophotometers. Agilent's stock is traded on the New York Stock Exchange under the symbol "A."

Pros and Cons of Agilent Technologies Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Agilent Technologies Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Agilent Technologies Inc. -0.320% -6.832% -4.493% -20.847% -25.486% -23.008% 15.090%
Veeva Systems A -0.120% -0.579% -1.110% 42.730% 18.356% 14.360% 7.896%
Thermo Fisher Scientific Inc. 2.270% -4.925% 0.304% -29.458% -30.610% -38.477% -0.986%
Waters Corp. -0.370% -7.592% -19.934% -17.040% -32.227% -25.663% 24.227%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-14

Upon initial review, the financials of Agilent Technologies (US Symbol: A) from the Healthcare Equipment & Supplies industry appear to show steady growth and financial stability. The company has managed to increase its net income and total assets over the past few years, suggesting a strong and expanding financial position. This combined with a generally positive industry trend makes Agilent Technologies an interesting player in the healthcare equipment and supplies sector.

Pros

Revenue Growth: From 2020 to 2022, Agilent's total revenue increased from $5.34 billion to $6.85 billion, demonstrating consistent growth. This steady uptick in revenues suggests promising business prospects and an expanding market share in the industry.

Comments

Agilent Technologies, Inc. (NYSE: A) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for A provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -2.68%
Target price 118.854
Change
Ends at 30.05.26

Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Leerink Partners to $135.00. They now have a "buy" rating on the stock.
Ratings data for A provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.61%
Target price 137.749
Change
Ends at 29.05.26

Agilent Technologies, Inc. (NYSE: A) had its price target lowered by analysts at JPMorgan Chase & Co. from $160.00 to $155.00. They now have an "overweight" rating on the stock.
Ratings data for A provided by MarketBeat
Show more

News

Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27


Following an announcement earlier this week, Agilent Technologies Inc. (NYSE: A) confirms it will release financial results for the third quarter of fiscal year 2025 after the stock market closes

Agilent Announces CFO Transition:
Agilent Announces CFO Transition


Agilent Technologies Inc. (NYSE: A) today announced that effective July 31, Senior Vice President and Chief Financial Officer Bob McMahon will step down from his role as he relocates to the East

Agilent to Showcase New Products and Innovations at HPLC 2025
Agilent to Showcase New Products and Innovations at HPLC 2025


Agilent Technologies Inc. (NYSE: A) today announced that they will introduce their latest Hybrid Multisampler and highlight the new LC Single Quadrupole Mass Spectrometers at the upcoming HPLC 2025